The new software platform ensures the integrity of electronic data records that are generated under industry-standard protocols within pharma research. NexION ES has been developed for pharma lab
The assay is designed to be used on the company’s cobas e 601 analyzer, an immunoassay module of the cobas 6000 analyzerseries. The Anti-HBc IgM assay is used
In addition, the companies also entered two other influenza-related, non-exclusive license agreements and a sponsored research agreement. As per the deal, Alios will sponsor collaborative research at the
The study had been commenced in September 2011 in five European countries. Purethal Mites is a modified aluminum hydroxide-adsorbed extract of house dust mites for subcutaneous use, to
Initially, Lilly committed $70m to launch the partnership, to fight against multidrug-resistant tuberculosis (MDR-TB) and transfer technology for two Lilly medicines used to treat MDR- TB to other
Astex has utilized its proprietary fragment-based drug discovery approach – Pyramid to target an unknown allosteric binding site on the full length HCV NS3 protease – helicase complex.
According to the company, its focus on therapeutics that target the epithelial-mesenchymal transition (EMT) in cancer supports the development of BGB324. BerGenBio CEO Richard Godfrey said inhibition of
VGX-100 is a human antibody that acts against the human VEGF-C protein. VGX-100 when combined with Avastin and chemotherapy, demonstrated reduced tumour growth and tumour spread, and improved
Exparel is a multivesicular liposomal combined therapy product including bupivacaine with a delivery technology – DepoFoam. Exparel with DepoFoam delivers bupivacaine for an extended period of time, providing
The agreement is said to provide Charles River’s clients with services including GMP-compliant protein analytics, detailed protein characterization and lot release testing. Through the partnership, the companies can
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.